VF 3 PN16 100/145 3-way seated flange
065B1685
VF 3 PN16 100/145 3-way seated flange
065B1685
Product specifications
Characteristic | Value |
|---|---|
| Application | Heating and cooling |
| Application alternative VSP | District heating |
| Cavitation factor | 0.40 |
| China RoHS compliance | Out of scope |
| Closing differential pressure (diverting) [bar] [Max] | 0.6 bar |
| Closing differential pressure (mixing) [bar] [Max] | 1.5 bar |
| Connection types | Flange |
| Contains batteries | No |
| Control ratio | 100:1 |
| Description | VF 3 PN16 100/145 3-way seated flange |
| DG Indicator Profile | Not relevant for dangerous goods |
| Diameter [mm] | 100 mm |
| EU RoHS compliance | Out of scope |
| Flow characteristic | Equal percentage |
| Function | Mixing valve |
| Kvs values [m³/h] | 145.00 m³/h |
| Leakage through port max. [% Kvs] | 0.05 |
| Material Description | VF 3 PN16 100/145 3-way seated flange |
| Media pH [Max] | 10 |
Characteristic | Value |
|---|---|
| Media pH [Min] | 7 |
| Media temperature [°C] [Max] | 130 °C |
| Media temperature [°C] [Min] | -10 °C |
| Medium alternative | Glycolic water up to 50% |
| Number of ports | 3 |
| Permissible media | District heating/cooling circulation water |
| PN alternative VSP | 10 |
| Pressure nominal [bar] | 16 bar |
| Product group | Other valves |
| Product line | Hydronic Balancing and Controls |
| Product Type | VF 3 |
| REACH Candidate List substances | Lead (CAS no. 7439-92-1) |
| SCIP dossier no. | 857da2cb-c3e1-4a88-9684-c1ee12d216c4 |
| SCIP dossier product name | VF 3 PN16 100/145 3-WAY SEATED FLANGE |
| Stroke [mm] | 30.00 mm |
| Stuffing box sealing material | EPDM |
| Valve body material | Grey cast iron EN-GJL-250 (GG-25) |
| Valve cone material | Red bronze CuSn5Zn5Pb5 (Rg 6) |
| Valve stem material | Stainless steel |
General specifications
Characteristic | Value |
|---|---|
| Gross weight | 38.6 Kilogram |
| Net weight | 38.6 Kilogram |
| Volume | 91.2 Liter |
Characteristic | Value |
|---|---|
| EAN/UPC | 5702421510933 |
| Proposition 65 | Cancer and Reproductive Harm |